Capital Group Private Client Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$46.5M Buy
104,537
+78,905
+308% +$35.1M 0.4% 62
2025
Q1
$12.4M Buy
+25,632
New +$12.4M 0.12% 133
2022
Q2
Sell
-57,226
Closed -$14.9M 238
2022
Q1
$14.9M Buy
57,226
+60
+0.1% +$15.7K 0.16% 123
2021
Q4
$12.6M Sell
57,166
-4,971
-8% -$1.09M 0.13% 127
2021
Q3
$11.3M Buy
+62,137
New +$11.3M 0.13% 126